Australia's most trusted
source of pharma news
Thursday, 06 February 2025
Posted 31 January 2025 PM
After a year of downsizing across Australian pharma, refreshing news of a hiring spree had our readers clicking, making it our top story this week.
Boehringer Ingelheim is embarking on its largest recruitment drive in more than 10 years to grow its medical field force by 75 per cent to boost its cardio-rental-metabolism portfolio which is spearheaded by heart failure drug Jardiance and diabetes medication Trajenta. It translates to 50-plus new rep hires across Australia.
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.